Fig. 2From: Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplantOverall survival of two cohorts: HID, 3-year OS of 86.1% ± 3.7%; MRD, 3-year OS of 91.3% ±3.4% (P = 0.358)Back to article page